Related Experiment Video
Updated: Jun 13, 2026

Production of Nurr-1 Specific Polyclonal Antibodies Free of Cross-reactivity Against Its Close Homologs, Nor1 and Nur77
Published on: August 17, 2015
Regulation of vascular smooth muscle cell proliferation by nuclear orphan receptor Nur77
Liyue Wang1, Fan Gong, Xiaoyan Dong
1Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, No 1277 Jiefang Avenue, Wuhan, 430020 Hubei, China.
Abstract:
It has been reported that Nur77 over-expresses in arteriosclerotic lesions and has both pro- and anti-proliferative effects on vascular smooth muscle cells (VSMCs). We investigated the physiological function of Nur77 on proliferation in VSMCs and the effects of atorvastatin on the expression of Nur77. Platelet-derived growth factor (PDGF), a key growth factor mediating VSMC proliferation in atherogenesis and post-angioplasty restenosis, was employed to induce the transcriptional regulation of Nur77 expression in VSMCs and rat carotid artery post-angioplasty restenosis models were used to investigate the effect of atorvastatin on the expression of Nur77 by immunohistochemistry, RT-PCR, and western blot methods. In cell models, we found that PDGF-B induced Nur77 mRNA expression and protein expression through ERK-MAPK-dependent signaling pathways, and atorvastatin attenuated the expression of Nur77 induced by PDGF-B. In the rat model, our data showed Nur77 was up-regulated in neointima, but down-regulated by atorvastatin. Our results indicate that Nur77 promotes VSMC proliferation, and down-regulation of Nur77 by atorvastatin suggests a novel therapy strategy for atherogenesis based on suppression of VSMC proliferation.
Insights
Nur77 promotes vascular smooth muscle cell proliferation in arteriosclerosis. Atorvastatin down-regulates Nur77, suggesting a new therapeutic strategy for preventing artery narrowing by inhibiting cell growth.
Area of Science:
- Vascular Biology
- Molecular Medicine
- Pharmacology
Background:
- Nur77 is implicated in arteriosclerosis, with reported dual effects on vascular smooth muscle cell (VSMC) proliferation.
- Platelet-derived growth factor (PDGF) is a key mediator of VSMC proliferation in atherogenesis and restenosis.
Purpose of the Study:
- To investigate the role of Nur77 in VSMC proliferation.
- To examine the effect of atorvastatin on Nur77 expression in VSMCs and in a rat restenosis model.
Main Methods:
- Cellular models of VSMC proliferation induced by PDGF-B.
- Rat carotid artery restenosis model.
- Immunohistochemistry, RT-PCR, and Western blot analysis to assess Nur77 expression.
- ERK-MAPK signaling pathway analysis.
Main Results:
- PDGF-B upregulated Nur77 mRNA and protein expression in VSMCs via ERK-MAPK signaling.
- Atorvastatin attenuated PDGF-B-induced Nur77 expression in VSMCs.
- In the rat model, Nur77 was upregulated in neointima and downregulated by atorvastatin treatment.
Conclusions:
- Nur77 promotes VSMC proliferation, contributing to arteriosclerosis.
- Atorvastatin's downregulation of Nur77 offers a potential therapeutic strategy for atherogenesis by suppressing VSMC proliferation.
More Related Videos
10:51Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
Published on: November 15, 2013
08:28Isolation of Primary Patient-specific Aortic Smooth Muscle Cells and Semiquantitative Real-time Contraction Measurements In Vitro
Published on: February 15, 2022
Related Concept Videos
Regulation of Nuclear Protein Sorting
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Abnormal Proliferation
Abnormal Proliferation
Regulation of Angiogenesis and Blood Supply
TGF - β Signaling Pathway